Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1CNS 1

Conditions

Neoplasms 4Lung Neoplasms 4Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 3Lymphoma 2Head and Neck Neoplasms 2Colorectal Neoplasms 2Carcinoma, Squamous Cell 2Brain Neoplasms 2Adenocarcinoma 2Urticaria 1Tuberous Sclerosis 1Thrombosis 1Squamous Cell Carcinoma of Head and Neck 1Smoking 1Small Cell Lung Carcinoma 1Severe Combined Immunodeficiency 1Sarcoma 1Salivary Gland Neoplasms 1Renal Insufficiency, Chronic 1Rectal Neoplasms 1Prostatic Neoplasms 1Primary Dysautonomias 1Polycythemia Vera 1Polycythemia 1Polycystic Ovary Syndrome 1Pancreatitis, Chronic 1Pancreatitis 1Pancreatic Cyst 1Ovarian Neoplasms 1

Interventions

Prospective Studies 1Phlebotomy 1Follow-Up Studies 1Cancer Vaccines 1Biological Specimen Banks 1Adalimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Mucopolysaccharidosis I × Phlebotomy × Clear all
NCT00695279 2024-10-30

Long Term Follow Up Of Patients Who Have Received Gene Therapy Or Gene Marked Products

St. Jude Children's Research Hospital

Completed
41 enrolled
CNSOther hematologic neoplasm

Mucopolysaccharidosis I, Neoplasms, Neuroblastoma, Severe Combined Immunodeficiency, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡